Idursulfase
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01271 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 15 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | ptosis-strabismus-ectopic pupils syndrome | KG + DL |
| 2 | camptodactyly, myopia, and fibrosis of the medial rectus muscle of eye | KG + DL |
| 3 | congenital Horner syndrome (disease) | KG + DL |
| 4 | ptosis-vocal cord paralysis syndrome | KG + DL |
| 5 | ptosis-upper ocular movement limitation-absence of lacrimal punctum syndrome | KG + DL |
| 6 | jaw-winking syndrome | KG + DL |
| 7 | congenital entropion | KG + DL |
| 8 | epiblepharon | KG + DL |
| 9 | congenital ectropion | KG + DL |
| 10 | Scheie syndrome | KG + DL |
| 11 | Steel syndrome | KG + DL |
| 12 | inborn disorder of lysosomal amino acid transport | KG + DL |
| 13 | proximal myopathy with extrapyramidal signs | KG + DL |
| 14 | Hurler syndrome | KG + DL |
| 15 | Charcot-Marie-Tooth disease | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.